Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Thymoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Uterine Prolapse 1Prostatic Neoplasms 1Prostatic Diseases 1Precancerous Conditions 1Pelvic Organ Prolapse 1Ovarian Neoplasms 1Obesity, Morbid 1Myasthenia Gravis 1Menstruation Disturbances 1Mediastinal Neoplasms 1Leiomyoma 1Hernia, Ventral 1Hernia, Inguinal 1Genital Diseases, Female 1Endometriosis 1Colonic Neoplasms 1Adenomyosis 1

Interventions

rozanolixizumab 10zilucoplan 7ravulizumab 7efgartigimod alfa 6eculizumab 5fludarabine 4Cyclophosphamide 4telitacicept 3Tacrolimus 3HBM9161 3inebilizumab 2Mycophenolic Acid 2Diagnostic Self Evaluation 2Amifampridine 2satralizumab 1rhoA GTP-Binding Protein 1remibrutinib 1iscalimab 1iptacopan 1Robotic Surgical Procedures 1Prednisone 1Prednisolone 1Plasmapheresis 1Immunoglobulins, Intravenous 1Data Collection 1Cladribine 1CK-2017357 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Myasthenia Gravis × Robotic Surgical Procedures × Clear all
NCT05150210 2025-12-23

SP Thoracic IDE Study

Intuitive Surgical

Phase NA Active not recruiting
32 enrolled 8 charts
Thoracic

Myasthenia Gravis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡